Drug Approval | September 02, 2025
FDA approves Sanofi’s BTK inhibitor for immune thrombocytopenia
ITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life
ITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life
The sudden subsequent decision to suspend IXCHIQ is based on updated VAERS data
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
NATCO holds the first-to-file status for this product and will have 180-day generic drug exclusivity
Morepen Laboratories has reported total income of Rs. 429.64 crores during the period ended June 30, 2025
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
Reblozyl is a standard of care for the first-line treatment of anemia without previous erythropoiesis stimulating agent use
Subscribe To Our Newsletter & Stay Updated
